Bharti reported Q4FY13 results with revenue 1.3% below expectations; however, Ebitda (earnings before interest, taxes, depreciation and amortisation) was 1% above our expectations
Dr Reddy’s Laboratories reported results in line with expectations led by a strong performance by the pharmaceuticals services and active ingredients (PSAI) business
Bharti reported Q4FY13 results with revenue 1.3% below expectations; however, Ebitda (earnings before interest, taxes, depreciation and amortisation) was 1% above our expectations
Bharti reported Q4FY13 results with revenue 1.3% below expectations; however, Ebitda (earnings before interest, taxes, depreciation and amortisation) was 1% above our expectations